Heraeus Precious Metals

Heraeus Precious Metals is a global leader in the precious metals industry and a critical supplier to the pharmaceutical sector, specializing in the development and large-scale production of platinum-based Active Pharmaceutical Ingredients (APIs). The company provides a comprehensive portfolio of cytotoxic compounds, including cisplatin, carboplatin, and oxaliplatin, which are foundational in oncology treatments worldwide. Beyond API manufacturing, Heraeus offers Contract Development and Manufacturing Organization (CDMO) services for highly potent APIs (HPAPIs), supporting clients from clinical phases through to commercialization. Their expertise encompasses the entire precious metal lifecycle, from sourcing and trading to high-purity chemical processing and recycling. The company is a business unit of the family-owned Heraeus Group and operates a global network of production sites.